Oren Livnat

Stock Analyst at HC Wainwright & Co.

(3.65)
# 788
Out of 5,152 analysts
124
Total ratings
54.62%
Success rate
23.49%
Average return

Stocks Rated by Oren Livnat

Pacira BioSciences
Apr 8, 2025
Maintains: Buy
Price Target: $48$65
Current: $22.86
Upside: +184.34%
Verrica Pharmaceuticals
Apr 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.33
Upside: -
Collegium Pharmaceutical
Mar 24, 2025
Reiterates: Buy
Price Target: $50
Current: $39.61
Upside: +26.23%
Trevi Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $13
Current: $12.92
Upside: -3.25%
ANI Pharmaceuticals
Mar 17, 2025
Reiterates: Buy
Price Target: $94
Current: $76.53
Upside: +22.83%
Zevra Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $20
Current: $8.93
Upside: +123.96%
Jazz Pharmaceuticals
Mar 10, 2025
Maintains: Buy
Price Target: $200$217
Current: $188.69
Upside: +15.00%
Xeris Biopharma Holdings
Mar 7, 2025
Reiterates: Buy
Price Target: $6.6$8
Current: $6.07
Upside: +31.80%
Tarsus Pharmaceuticals
Feb 26, 2025
Reiterates: Buy
Price Target: $73
Current: $76.20
Upside: -4.20%
Grace Therapeutics
Feb 18, 2025
Reiterates: Buy
Price Target: $12
Current: $3.87
Upside: +210.08%
Reiterates: Buy
Price Target: $7.5
Current: $2.95
Upside: +154.24%
Maintains: Buy
Price Target: $14$8
Current: $0.78
Upside: +932.26%
Maintains: Buy
Price Target: $43$60
Current: $8.43
Upside: +605.81%
Maintains: Buy
Price Target: $252$198
Current: $0.59
Upside: +33,295.18%